Schering Corporation and Pharmacopeia, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Schering Corporation and Pharmacopeia, Inc..The latest application filed is for "heterocyclic substituted piperazine compounds with cxcr3 antagonist activity".
- Schering Corporation and Pharmacopeia, Inc. -
| Patent | Date |
|---|---|
| Heterocyclic Substituted Piperazine Compounds With Cxcr3 Antagonist Activity App 20080058343 - Rosenblum; Stuart B. ; et al. | 2008-03-06 |
| Functionally selective alpha2C adrenoreceptor agonists App 20080027100 - McCormick; Kevin D. ; et al. | 2008-01-31 |
| 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20070021494 - Taveras; Arthur G. ; et al. | 2007-01-25 |
| Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ; et al. | 2004-10-21 |
| Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands App 20040186142 - Taveras, Arthur G. ; et al. | 2004-09-23 |
| Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102451 - Guzi, Timothy J. ; et al. | 2004-05-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 